Johnson & Johnson

Johnson & Johnson is a healthcare company operating through two main areas: a medicines business covering oncology, immunology, neuroscience and cardiopulmonary conditions, and a medical technology business covering cardiovascular treatment, orthopaedics, surgery and vision, aimed at less invasive and more precisely targeted procedures. The company references work on conditions including warm autoimmune haemolytic anaemia and prostate cancer, and describes manufacturing CAR-T cell therapy for multiple myeloma, a process it says involves converting a patient's own cells into a targeted treatment; its site includes an account from Jessica Torfs, director of Global CAR-T Supply Chain, describing that process. Johnson & Johnson publishes quarterly earnings updates, including results covering its medicines and medical technology businesses, alongside patient-focused material about the conditions its treatments address and information about career opportunities at the company.